Naslov
Refeeding syndrome in hospitalized children and adolescents with eating disorders- experience of tertiary center.

Autori
Perše, Barbara ; Kovačević, Ana ; Kološa, Andrijana ; Crnković-Ćuk, Matea ; Žaja, Orjena

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
BMJ Archives of Disease in Childhood vol.106 suppl.2 / - , 2021, 108-108

Skup
10th Congress of European Paediatric Association EPA/UNEPSA jointly held with 14 th Congress of Croatian Paediatric Society

Mjesto i datum
Zagreb, Hrvatska, 07.10.2021. - 09.10.2021

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
refeeding syndrome ; anorexia nervosa ; childhood ; hypophosphatemia

Sažetak
Refeeding syndrome (RFS) describes a potentially fatal shift in electrolytes in severely malnourished patients receiving rapid and excessive food re-introduction. It is a result of hormonal and metabolic disturbances. There are various clinical and laboratory features with hypophosphatemia being the most common one. Elevation in liver function tests is also frequently seen. Patients with anorexia are a high-risk group for developing RFS. The aim of the study was to investigate the incidence and clinical features of RFS among hospitalized patients, as well as the severity of malnutrition (Z-score, BMI). This study is a retrospective analysis of medical documentation of patients diagnosed with anorexia nervosa (restricting (ANRT) and binge eating/purging (ANBP) subtype), eating disorder NOS (EDNOS), and avoidant/ restrictive food intake disorder (ARFID) who were admitted to our Centre for eating disorders in children and adolescents during a 5 year period (2014-2018). We analyzed the age, gender, duration of the disease before admittance, anthropometric data (BMI and Z-score), average weight loss, the need for nasogastric (NG) tube feeding, and phosphate supplementation. For statistical analysis we used t-test. 256 patients (232 female) aged 6-20 years (median 15+/-2.06) of which 43% were diagnosed with ANRT, 10% ANBP, 8% ARFID, 39% with EDNOS were included in the study. The average duration of the disease at the time of admittance was 13.25+/-13.43 months. The average BMI Z-score was -1.97 +/-1.63 average weight loss was 20+/-9.76% initial body weight (IBW). Hypophosphatemia was found in 15.6% of patients, of which 65% received phosphate supplements by oral or intravenous route depending on phosphate serum concentration. Elevated liver enzymes due to RFS were found in 9.3% of patients. In total RFS in some form developed in 23% of patients. The average BMI Z-score of patients that developed RFS was -2.6+/-1.89, average weight loss was 23.9+/-9.85% of IBW. Both variables were significantly different (p<0.05) in comparison with non-RFS group which had a BMI Z-score of -1.76+/-1.47 and an average weight loss of 18.7+/-9.3% of IBW. The average duration of the disease was similar in both groups (13 months) (p=0.84). NG tube feeding was needed in 27% of all patients, 24% patients in the non- RFS group, and 37% in patients with RFS. Our study reported that even in controlled hospital conditions and with careful realimentation RFS has a high incidence. We found a statistically significant differences when it comes to BMI Z-score and average weight loss between two groups of patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA